![Florencia Segal](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Florencia Segal
Directeur/Membre du Conseil chez Antiva Biosciences, Inc.
Profil
Dr. Florencia Segal is a Partner at MPM BioImpact, Inc. She is on the Board of Directors at Antiva Biosciences, Inc.
She received her doctorate degree from Central University of Venezuela.
Postes actifs de Florencia Segal
Sociétés | Poste | Début |
---|---|---|
MPM BioImpact, Inc
![]() MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Private Equity Investor | 01/11/2022 |
Antiva Biosciences, Inc.
![]() Antiva Biosciences, Inc. BiotechnologyHealth Technology Antiva Biosciences, Inc. is a biopharmaceutical company developing novel, topical therapeutics for the treatment of diseases caused by HPV infection. The company was founded by Karl Y. Hostetler in 2012 and is headquartered in South San Francisco, CA. | Directeur/Membre du Conseil | 01/04/2023 |
Formation de Florencia Segal
Central University of Venezuela | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
MPM BioImpact, Inc
![]() MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Finance |
Antiva Biosciences, Inc.
![]() Antiva Biosciences, Inc. BiotechnologyHealth Technology Antiva Biosciences, Inc. is a biopharmaceutical company developing novel, topical therapeutics for the treatment of diseases caused by HPV infection. The company was founded by Karl Y. Hostetler in 2012 and is headquartered in South San Francisco, CA. | Health Technology |